Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeSST2: Non-invasive Short Synacthen Test
NCT03514589Phase 2Recruiting
- Sponsor
- Sheffield Children's Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracosactide hexaacetate in adrenal insufficiency (AI), sponsored by Sheffield Children's Hospital. Started Oct 2012; status: recruiting.
02
Drugs
tetracosactide hexaacetate
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT03514589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514589.